NO942376D0 - - Google Patents

Info

Publication number
NO942376D0
NO942376D0 NO942376A NO942376A NO942376D0 NO 942376 D0 NO942376 D0 NO 942376D0 NO 942376 A NO942376 A NO 942376A NO 942376 A NO942376 A NO 942376A NO 942376 D0 NO942376 D0 NO 942376D0
Authority
NO
Norway
Prior art keywords
alkyl
represents hydrogen
halo
alkoxy
pct
Prior art date
Application number
NO942376A
Other languages
English (en)
Norwegian (no)
Other versions
NO942376L (no
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO942376D0 publication Critical patent/NO942376D0/no
Publication of NO942376L publication Critical patent/NO942376L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO942376A 1991-12-23 1994-06-22 Terapeutiske midler NO942376L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919127252A GB9127252D0 (en) 1991-12-23 1991-12-23 Therapeutic agents
PCT/EP1992/002901 WO1993013097A1 (en) 1991-12-23 1992-12-12 Anti-rheumatic naphthyridine derivatives
CN93109454A CN1096784A (zh) 1991-12-23 1993-06-22 含取代4(5)-氨基-1,8-二氨杂萘的治疗剂

Publications (2)

Publication Number Publication Date
NO942376D0 true NO942376D0 (OSRAM) 1994-06-22
NO942376L NO942376L (no) 1994-06-22

Family

ID=36822317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942376A NO942376L (no) 1991-12-23 1994-06-22 Terapeutiske midler

Country Status (22)

Country Link
US (1) US5464781A (OSRAM)
EP (1) EP0618916B1 (OSRAM)
JP (1) JP2527917B2 (OSRAM)
CN (1) CN1096784A (OSRAM)
AT (1) ATE171452T1 (OSRAM)
AU (1) AU656832B2 (OSRAM)
BG (1) BG98813A (OSRAM)
CA (1) CA2125858A1 (OSRAM)
CZ (1) CZ153594A3 (OSRAM)
DE (1) DE69227125T2 (OSRAM)
FI (1) FI943019A7 (OSRAM)
GB (1) GB9127252D0 (OSRAM)
HR (1) HRP921455A2 (OSRAM)
HU (1) HUT66971A (OSRAM)
IL (1) IL104169A0 (OSRAM)
IN (1) IN174405B (OSRAM)
MX (1) MX9207494A (OSRAM)
NO (1) NO942376L (OSRAM)
NZ (1) NZ246156A (OSRAM)
SI (1) SI9200408A (OSRAM)
SK (1) SK75094A3 (OSRAM)
WO (1) WO1993013097A1 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
CA2263479A1 (en) 1996-09-25 1998-04-02 Zeneca Limited Quinoline derivatives inhibiting the effect of growth factors such as vegf
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
US6166069A (en) * 1998-05-12 2000-12-26 American Home Products Corporation Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6933299B1 (en) 1999-07-09 2005-08-23 Smithkline Beecham Corporation Anilinoquinazolines as protein tyrosine kinase inhibitors
DE60037020T2 (de) 1999-07-09 2008-08-21 Glaxo Group Ltd., Greenford Anilinochinazoline als protein-tyrosin-kinasehemmer
CN1240688C (zh) 2000-04-07 2006-02-08 阿斯特拉曾尼卡有限公司 喹唑啉化合物
US6534656B2 (en) * 2001-05-31 2003-03-18 North Carolina State University Short synthesis of pyridine-based pharmaceutical intermediates
JP2003329989A (ja) * 2002-03-06 2003-11-19 Nippon Telegr & Teleph Corp <Ntt> 光送信装置
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US7618975B2 (en) 2003-07-03 2009-11-17 Myriad Pharmaceuticals, Inc. 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2005063739A1 (en) 2003-12-23 2005-07-14 Pfizer Inc. Novel quinoline derivatives
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
EP1971611B1 (en) * 2005-12-21 2012-10-10 Abbott Laboratories Anti-viral compounds
CA2633760A1 (en) * 2005-12-21 2007-07-05 Abbott Laboratories Anti-viral compounds
NZ569817A (en) * 2005-12-21 2011-10-28 Abbott Lab Anti-viral compounds
TW200738707A (en) * 2005-12-21 2007-10-16 Abbott Lab Anti-viral compounds
EP2345652A1 (en) 2005-12-21 2011-07-20 Abbott Laboratories Antiviral compounds
US8236950B2 (en) 2006-12-20 2012-08-07 Abbott Laboratories Anti-viral compounds
BRPI0914936A2 (pt) * 2008-07-03 2015-10-20 Merck Patent Gmbh naftiridininonas como inibidores de aurora quinase
ES2432070T3 (es) 2009-02-24 2013-11-29 Respiratorius Ab Diazaheteroarilos broncodilatadores novedosos
WO2011063398A1 (en) * 2009-11-23 2011-05-26 Cylene Pharamaceuticals, Inc. Polymorphs and salts of a kinase inhibitor
RU2605549C2 (ru) 2010-04-02 2016-12-20 Синомикс, Инк. Производные 3-карбокси-4-аминохинолина, полезные как модификаторы сладкого вкуса

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
EP0222839A4 (en) * 1985-05-17 1988-11-09 Univ Australian ANTI-MALARIA COMPOUNDS.
JPS6368568A (ja) * 1986-09-10 1988-03-28 Otsuka Pharmaceut Factory Inc p−アミノフエノ−ル誘導体
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
GB8804443D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US4978661A (en) * 1988-09-29 1990-12-18 Innocenzo Caruso Use of 6-halo-4-quinolone compounds and pharmaceutical compositions thereof for the preparation of a medicament for the therapeutical application in rheumatoid arthritis
GR900100380A (el) * 1989-05-20 1991-10-10 Fisons Plc Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
AU634561B2 (en) * 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
JP2988739B2 (ja) * 1990-04-16 1999-12-13 協和醗酵工業株式会社 1,8−ナフチリジン−2−オン誘導体
JP3157077B2 (ja) * 1994-02-16 2001-04-16 内山工業株式会社 ベアリングシール

Also Published As

Publication number Publication date
JPH07502280A (ja) 1995-03-09
AU656832B2 (en) 1995-02-16
AU3158793A (en) 1993-07-28
NO942376L (no) 1994-06-22
US5464781A (en) 1995-11-07
JP2527917B2 (ja) 1996-08-28
CZ153594A3 (en) 1995-02-15
SK75094A3 (en) 1995-04-12
BG98813A (bg) 1995-05-31
DE69227125T2 (de) 1999-02-18
EP0618916B1 (en) 1998-09-23
HUT66971A (en) 1995-01-30
CA2125858A1 (en) 1993-07-08
HRP921455A2 (en) 1994-12-31
NZ246156A (en) 1996-01-26
MX9207494A (es) 1993-07-01
ATE171452T1 (de) 1998-10-15
DE69227125D1 (de) 1998-10-29
IL104169A0 (en) 1993-05-13
EP0618916A1 (en) 1994-10-12
FI943019A0 (fi) 1994-06-22
IN174405B (OSRAM) 1994-11-26
GB9127252D0 (en) 1992-02-19
WO1993013097A1 (en) 1993-07-08
HU9401877D0 (en) 1994-09-28
SI9200408A (en) 1993-09-30
FI943019A7 (fi) 1994-06-22
CN1096784A (zh) 1994-12-28

Similar Documents

Publication Publication Date Title
NO942376D0 (OSRAM)
MY129425A (en) Indole derivatives useful a.o. for the treatment of osteoporosis
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
YU41199A (sh) Hinoksalindioni
GR3034769T3 (en) Triazole antifungal agents.
GB9305641D0 (en) Therapeutic agents
IL136735A0 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
PH30660A (en) Therapeutic agents
HU9402466D0 (en) Indole derivatives as steroid-5-alpha-reductase inhibitors
TW354780B (en) 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
JO1754B1 (en) Therapeutic agents
AUPO227896A0 (en) Novel compounds and their preparation
ZA952403B (en) New 2,4-diphosphonoglutaric acid derivatives processes for their production and pharmaceutical agents containing these compounds
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
JO1810B1 (en) Therapeutic agents
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
JO1755B1 (en) Therapeutic agents
MX9705378A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de la obesidad.